Short interest in UroGen Pharma Ltd (NASDAQ:URGN) decreased during the last reporting period, falling from 6.44M to 5.77M. This put 14% of the company's publicly available shares short.

Short interest for UroGen Pharma gives investors a sense of the degree to which investors are betting on the decline of UroGen Pharma's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 438.29K shares traded per day, it would take 13.17 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.